In this episode of the Psychedelic Spotlight Podcast, we put a spotlight on the unique and unsuspecting intersection where psychedelics and real estate are beginning to converge as the psychedelic industry moves closer to mass adoption.
Fireside Project’s Co-Founder and Director, Joshua White, speaks about the creation and the future of the organization.
The proposed bill would legalize the “possession and use of lysergic acid diethylamide (LSD), mescaline, psilocybin, and peyote for persons 21 years of age and older.”
Recent analysis cites positive results of clinical psychedelic trials, coupled with a large amount of capital investment into biotech companies.
In this much anticipated Psychedelic Spotlight podcast, we get to…
In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health issues and other disorders.
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
